News

Cerebrolysin® recommended in treatment guidelines of top reference countries!

Read more

New 3D videos about the mode of action of Cerebrolysin® are available

Read more

Innovative strategies to advance severe TBI treatment

Read more

Pilot-study combining recanalization methods with Cerebrolysin® shows strong positive signals

Read more

Breakthrough study results from Cerebrolysin® TBI studies

Read more

Strongest recommendation for Cerebrolysin®

Read more

EVER Webinar 2021 # 2 – Summary report

Read more

Reduction of tPA/fibrin-impaired BBB permeability

Read more

What are the European initiatives to reduce the burden of longterm disabilities after stroke and which are the successful rehabilitation concepts?

Read more

EVER Webinars 2021 # 1 – The Summary Report

Read more

Don’t miss the second EVER Pharma Webinar on 18th May from 12:00-13:30 (MEZ).

Read more

Cerebrolysin® recommended in treatment guidelines of top reference countries!

Read more

Cerebrolysin® after moderate to severe traumatic brain injury

Read more

Interview with an Austrian intensive care leader, Dr. Helmut Trimmel

Read more

CERECAP stands for CErebrolysin RECanalization And Perfusion

Read more

Interview with two stroke neurologists sharing their experiences

Read more

New Cerebrolysin® pilot study of Cerebrolysin® with COVID-19 patients in ICU

Read more

Cerebrolysin® included as best ranked pharmacological agent

Read more

Cerebrolysin® - Best ranked medication in DGNR Guidelines!

Read more

The role of Cerebrolysin® in thrombolysis and thrombectomy

Read more

A collection of practice-based evidence

Read more

20% patients suffer from DoC after stroke

Read more

NEW study available - Efficacy and safety of Cerebrolysin® in neurorecovery after moderate-severe TBI: results from CAPTAIN

Read more

Program received award 'The best Project of the Year' from the republic of Uzbekistan

Read more

Cerebrolysin® strongly improves impairment after stroke!

Read more

Detailed IMMM Report now available!

Read more

Get more information in the report of the EVER satellite symposium during the 5th EAN!

Read more

We are looking forward to meeting you at the ECNR 2019!

Read more

Invitation to the International Mondsee Medical Meeting in Salzburg, Austria, 12 - 13 September 2019

Read more

Please find a very detailed summary about the symposium 'Immediate neurorecovery treatment improves longterm outcome'!

Read more

Visit our symposium and get information about NEW TBI treatment

Read more

Visit the symposium on 23rd May!

Read more

More information in the interview with eminent stroke expert, Prof. Michael Brainin

Read more

EVER supports the WHO goal to establish community-based rehabilitation

Read more

Prim. Dr. Winkler talks about this new guideline, specifically about the inclusion of pharmacological compounds.

 

Read more

IMMM Report is available!

Read more

We asked the investigator Natan Bornstein, Vice-President of the WSO, for an interview!

Read more

Follow this link to download a very detailed summary about the EAN symposium.

Read more

Invitation to the 25th Mondsee Medical Meeting (IMMM) in Salzburg, Austria, 13 – 14 September 2018

Read more

Please find a very detailed summary about the symposium ‘New evidence for Multi-modal Treatment Concepts in Post-Stroke Recovery!

Read more

Visit the symposium on June 18th and get the EVER Rehabilitationset and Scales booklet for free!

Read more

Visit the symposium and get the EVER Rehabilitationset and Scales booklet for free.

Read more

Transcranial Direct Current Stimulation (tDCS) and multimodal pharmacological support can be future in chronic stroke treatment.

Read more

Get background information about the event and read the summary of two powerful satellite symposia organized by EVER.

Read more

Enjoy this NEW video and get more information about Cerebrolysin® and Recovery after stroke!

Read more

A commentary to the CARS trial by Prof. Anna Czlonkowska. (EMJ Neurol. 2017;5[1]:60-64)

Read more

Stroke Recovery - Pharmacological Treatment Concepts in the acute and sub-acute phase

Read more

Come to the EAN congress and get your free EVER Rehabilitation set!

Read more

EAN Congress, June 24-27th 2017

Amsterdam/The Netherlands

Read more

Summary of poster presentations during AD/PD

Read more

Visit the symposium and get the EVER Rehabilitationset for free.

Read more

- New findings on Cerebrolysin® in Fronto-Temporal Dementia

- Cognitive improvement in AD patients

Read more

This Post-Stroke Checklist (PSC) has been developed by an international group of Stroke experts. The PSC, which is endorsed by the World Stroke...

Read more

Symposium about advances in acute care of stroke and in the treatment of Complications and advances in Neurorehabilitation after Stroke

Read more

Pharmacological support in early rehabilitation - The CARS (Cerebrolysin® and Recovery After Stroke) Trial results.

Read more

Neurologisch – a well-known Austrian journal – reviewed the CARS results.

Read more

Review of the Scientific Symposium "Advances in Sub-Acute Stroke Motor Recovery"

Read more